Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Pyrrolcarboxamide Derivatives for the Inhibition of ERK5

Lookup NU author(s): Tristan Reuillon, Duncan MillerORCiD, Stephanie Myers, Dr Lauren Molyneux, Dr Celine CanoORCiD, Dr Ian HardcastleORCiD, Professor Roger Griffin, Dr Laurent Rigoreau, Emeritus Professor Bernard Golding, Professor Martin NobleORCiD

Downloads

Full text is not currently available for this publication.

Abstract

The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the prophylaxis or treatment of a disease state or condition mediated by ERK5, in particular cancers

Publication metadata

Inventor(s): Reuillon T, Miller D, Myers S, Molyneux L, Cano C, Hardcastle I, Griffin R, Rigoreau L, Golding B, Noble M

Publication type: Patent

Publication status: Published

Year: 2016

Print publication date: 24/03/2016

Acceptance date: 24/03/2016

Share